Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

459
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
459
COP Coated Vesicles00:59

COP Coated Vesicles

7.9K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
7.9K
Conjugated Proteins02:50

Conjugated Proteins

18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Applications, image analysis, and interpretation of computer vision in medical imaging.

Frontiers in radiology·2026
Same author

The IL-33/ST2/ILC2 pathway in kidney disease: balancing inflammation, fibrosis, and repair.

American journal of physiology. Cell physiology·2025
Same author

Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups.

Current issues in molecular biology·2025
Same author

NKT cell deficiency exacerbates adenine-induced renal fibrosis through enhanced Treg infiltration and TGF-β expression.

American journal of physiology. Cell physiology·2025
Same author

Comparative analysis of virulence-associated genes in ESBL-producing <i>Escherichia coli</i> isolates from bloodstream and urinary tract infections.

Frontiers in microbiology·2025
Same author

Therapeutic Application and Structural Features of Adeno-Associated Virus Vector.

Current issues in molecular biology·2024

Related Experiment Video

Updated: Aug 5, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.6K

Extracellular Vesicle-Based SARS-CoV-2 Vaccine.

Yasunari Matsuzaka1,2, Ryu Yashiro2,3

  • 1Division of Molecular and Medical Genetics, The Institute of Medical Science, Center for Gene and Cell Therapy, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.

Vaccines
|March 30, 2023
PubMed
Summary

Extracellular vesicles (EVs) encapsulating viral vectors offer a safer alternative to traditional vaccines. This approach explores the cellular mechanisms behind novel EV-based vaccines for SARS-CoV-2.

Keywords:
SARS-CoV-2drug deliveryexosomesextracellular vesicleslipid nanoparticleviral vector

More Related Videos

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.1K

Related Experiment Videos

Last Updated: Aug 5, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.6K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.1K

Area of Science:

  • Biotechnology
  • Immunology
  • Vaccinology

Background:

  • Messenger RNA (mRNA) vaccines are primarily used for SARS-CoV-2, but face challenges like storage and stability.
  • Viral vector vaccines, despite issues, are utilized for various diseases.
  • Extracellular vesicles (EVs) encapsulating viral vectors are emerging as promising vaccine tools due to safety and immune evasion.

Purpose of the Study:

  • To summarize the potential cellular mechanisms of extracellular vesicle (EV)-based vaccines for SARS-CoV-2.
  • To highlight the advantages of EV-based vaccine technology.

Main Methods:

  • Literature review and synthesis of current research on EV-based vaccine platforms.
  • Analysis of cellular interactions and immune responses related to EV delivery systems.

Main Results:

  • EVs offer a safe delivery system for viral vectors.
  • EVs can evade neutralizing antibodies, enhancing vaccine efficacy.
  • Understanding cellular mechanisms is key to optimizing EV-based vaccine design.

Conclusions:

  • EV-based vaccines represent a promising advancement in vaccine technology.
  • Further research into cellular mechanisms will refine the development of effective EV-based SARS-CoV-2 vaccines.